BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21795433)

  • 1. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion.
    Oyamada S; Bianchi C; Takai S; Chu LM; Sellke FW
    J Pharmacol Exp Ther; 2011 Oct; 339(1):143-51. PubMed ID: 21795433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats.
    Zhang W; Han Y; Meng G; Bai W; Xie L; Lu H; Shao Y; Wei L; Pan S; Zhou S; Chen Q; Ferro A; Ji Y
    J Am Heart Assoc; 2014 Jan; 3(1):e000606. PubMed ID: 24473199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chymase inhibition prevents cardiac fibrosis and dysfunction after myocardial infarction in rats.
    Kanemitsu H; Takai S; Tsuneyoshi H; Nishina T; Yoshikawa K; Miyazaki M; Ikeda T; Komeda M
    Hypertens Res; 2006 Jan; 29(1):57-64. PubMed ID: 16715654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.
    Li XD; Yang YJ; Geng YJ; Zhao JL; Zhang HT; Cheng YT; Wu YL
    Acta Pharmacol Sin; 2012 Jul; 33(7):879-87. PubMed ID: 22659627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zofenopril Protects Against Myocardial Ischemia-Reperfusion Injury by Increasing Nitric Oxide and Hydrogen Sulfide Bioavailability.
    Donnarumma E; Ali MJ; Rushing AM; Scarborough AL; Bradley JM; Organ CL; Islam KN; Polhemus DJ; Evangelista S; Cirino G; Jenkins JS; Patel RA; Lefer DJ; Goodchild TT
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27381758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J; Mauro AG; Devarakonda T; Marchetti C; He J; Kim E; Filippone S; Das A; Toldo S; Abbate A; Salloum FN
    Cardiovasc Res; 2017 May; 113(6):609-619. PubMed ID: 28073832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase inhibition reduces the progression to heart failure after autoimmune myocarditis in rats.
    Palaniyandi SS; Nagai Y; Watanabe K; Ma M; Veeraveedu PT; Prakash P; Kamal FA; Abe Y; Yamaguchi K; Tachikawa H; Kodama M; Aizawa Y
    Exp Biol Med (Maywood); 2007 Oct; 232(9):1213-21. PubMed ID: 17895529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of iNOS and peroxynitrite-matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats.
    Bencsik P; Kupai K; Giricz Z; Görbe A; Pipis J; Murlasits Z; Kocsis GF; Varga-Orvos Z; Puskás LG; Csonka C; Csont T; Ferdinandy P
    Am J Physiol Heart Circ Physiol; 2010 Aug; 299(2):H512-8. PubMed ID: 20543091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway.
    Bulhak AA; Jung C; Ostenson CG; Lundberg JO; Sjöquist PO; Pernow J
    Am J Physiol Heart Circ Physiol; 2009 Mar; 296(3):H719-27. PubMed ID: 19151258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.
    Liu Q; Li Z; Liu Y; Xiao Q; Peng X; Chen Q; Deng R; Gao Z; Yu F; Zhang Y
    Cardiovasc Ther; 2018 Dec; 36(6):e12481. PubMed ID: 30597772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes.
    Fang J; Wei Z; Zheng D; Ying T; Hong H; Hu D; Lin Y; Jiang X; Wu L; Lan T; Yang Z; Zhou X; Chen L
    J Am Heart Assoc; 2020 Jul; 9(13):e016047. PubMed ID: 32567476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium.
    Hamid SA; Bower HS; Baxter GF
    Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2598-606. PubMed ID: 17220176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioselective nitric oxide synthase 3 gene transfer protects against myocardial reperfusion injury.
    Szelid Z; Pokreisz P; Liu X; Vermeersch P; Marsboom G; Gillijns H; Pellens M; Verbeken E; Van de Werf F; Collen D; Janssens SP
    Basic Res Cardiol; 2010 Mar; 105(2):169-79. PubMed ID: 20020305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury.
    Hooshdaran B; Kolpakov MA; Guo X; Miller SA; Wang T; Tilley DG; Rafiq K; Sabri A
    Basic Res Cardiol; 2017 Sep; 112(6):62. PubMed ID: 28913553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
    Hwa JS; Jin YC; Lee YS; Ko YS; Kim YM; Shi LY; Kim HJ; Lee JH; Ngoc TM; Bae KH; Kim YS; Chang KC
    J Ethnopharmacol; 2012 Jan; 139(2):605-15. PubMed ID: 22179023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of matrix metalloproteinase 2 and 9 inhibitory action of minocycline by aspirin: an approach to attenuate outcome of acute myocardial infarction in diabetes.
    Bhatt LK; Veeranjaneyulu A
    Arch Med Res; 2014 Apr; 45(3):203-9. PubMed ID: 24606818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic drug pioglitazone protects the heart via activation of PPAR-gamma receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction.
    Yasuda S; Kobayashi H; Iwasa M; Kawamura I; Sumi S; Narentuoya B; Yamaki T; Ushikoshi H; Nishigaki K; Nagashima K; Takemura G; Fujiwara T; Fujiwara H; Minatoguchi S
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1558-65. PubMed ID: 19286954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early ischaemic preconditioning requires Akt- and PKA-mediated activation of eNOS via serine1176 phosphorylation.
    Yang C; Talukder MA; Varadharaj S; Velayutham M; Zweier JL
    Cardiovasc Res; 2013 Jan; 97(1):33-43. PubMed ID: 22977010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprostadil attenuates myocardial ischemia/reperfusion injury by promoting antioxidant activity and eNOS activation in rats.
    Zhang L; Zhang Y; Yu X; Xu H; Sui D; Zhao X
    Acta Cir Bras; 2018 Dec; 33(12):1067-1077. PubMed ID: 30624512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.